Wolfgang M Kuebler Selected Research

Chemokine CXCL2

1/2018	Impaired lung repair during neutropenia can be reverted by matrix metalloproteinase-9.
1/2017	Transient Receptor Potential Vanilloid 4 and Serum Glucocorticoid-regulated Kinase 1 Are Critical Mediators of Lung Injury in Overventilated Mice In Vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wolfgang M Kuebler Research Topics

Disease

19	Edema (Dropsy) 01/2021 - 01/2007
16	Hypoxia (Hypoxemia) 01/2022 - 10/2007
15	Lung Injury 01/2022 - 04/2006
14	Inflammation (Inflammations) 01/2022 - 03/2012
14	Pulmonary Hypertension 01/2022 - 01/2007
13	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 01/2011
13	Acute Lung Injury 01/2021 - 12/2006
11	COVID-19 06/2022 - 01/2020
10	Pneumonia (Pneumonitis) 01/2022 - 01/2009
9	Infections 01/2022 - 06/2015
9	Pulmonary Edema 01/2021 - 01/2009
7	Transfusion-Related Acute Lung Injury 01/2021 - 10/2010
6	Pulmonary Arterial Hypertension 01/2022 - 10/2014
6	Ventilator-Induced Lung Injury 07/2019 - 08/2010
6	Vascular Remodeling 01/2018 - 03/2011
5	Sepsis (Septicemia) 12/2020 - 10/2007
5	Hypertension (High Blood Pressure) 01/2018 - 01/2007
4	Human Influenza (Influenza) 01/2022 - 06/2015
4	Heart Failure 10/2020 - 01/2007
4	Fibrosis (Cirrhosis) 01/2019 - 06/2015
4	Lung Diseases (Lung Disease) 01/2019 - 12/2006
3	Critical Illness (Critically Ill) 06/2022 - 01/2022
3	Ischemia 02/2013 - 07/2004
3	Body Weight (Weight, Body) 10/2008 - 07/2004
2	Hypothermia 01/2022 - 10/2010
2	Respiratory Insufficiency (Respiratory Failure) 01/2022 - 05/2020
2	Bacterial Pneumonia 04/2021 - 01/2018
2	Hypertrophy 01/2021 - 06/2015
2	Shock 04/2018 - 01/2012
2	Myocardial Ischemia (Ischemic Heart Diseases) 08/2012 - 07/2004
2	Familial Primary Pulmonary Hypertension 02/2012 - 05/2011
2	Heart Diseases (Heart Disease) 12/2011 - 03/2009
2	Congenital Heart Defects (Congenital Heart Defect) 10/2008 - 07/2006
2	Postoperative Hemorrhage 02/2004 - 10/2002
1	Communicable Diseases (Infectious Diseases) 01/2022

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 10/2021 - 01/2009
11	Biomarkers (Surrogate Marker)IBA 09/2021 - 01/2011
7	AcidsIBA 01/2021 - 01/2009
6	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2015 - 10/2007
5	AntibodiesIBA 01/2022 - 01/2012
4	CollagenIBA 01/2022 - 01/2015
4	CytokinesIBA 01/2022 - 08/2010
4	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2017
4	CalciumIBA 01/2020 - 04/2006
4	MonocrotalineIBA 01/2018 - 05/2011
4	TRPC6 Cation ChannelIBA 07/2017 - 01/2012
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2021
3	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021 - 04/2006
3	Anti-Bacterial Agents (Antibiotics)IBA 04/2021 - 10/2015
3	Oxygen (Dioxygen)IBA 01/2021 - 04/2006
3	Sphingomyelin Phosphodiesterase (Sphingomyelinase)IBA 01/2021 - 01/2010
3	LipopolysaccharidesIBA 01/2021 - 10/2007
3	SphingolipidsIBA 01/2021 - 01/2017
3	Ion Channels (Ion Channel)IBA 06/2020 - 12/2018
3	Pharmaceutical PreparationsIBA 04/2018 - 06/2015
3	CationsIBA 07/2017 - 06/2015
3	angiotensin I (1-7)IBA 01/2016 - 11/2013
3	Vasodilator Agents (Vasodilators)IBA 01/2013 - 03/2009
3	Sildenafil Citrate (Viagra)FDA Link 01/2013 - 04/2008
2	Surface-Active Agents (Surfactants)IBA 01/2022 - 01/2018
2	FibrinIBA 01/2022 - 10/2002
2	Complement System Proteins (Complement)IBA 01/2022 - 01/2020
2	CeramidesIBA 01/2021 - 01/2017
2	Angiotensin-Converting Enzyme 2IBA 01/2021 - 11/2013
2	Myosin-Light-Chain KinaseIBA 01/2021 - 01/2010
2	GasesIBA 01/2021 - 01/2017
2	Biological ProductsIBA 01/2019 - 01/2016
2	Platelet Activating FactorIBA 01/2019 - 01/2010
2	Transcription Factors (Transcription Factor)IBA 12/2018 - 01/2017
2	sphingosine kinaseIBA 01/2018 - 03/2015
2	Chemokine CXCL2IBA 01/2018 - 01/2017
2	Angiotensin IIIBA 07/2017 - 11/2013
2	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2017 - 06/2013
2	LigandsIBA 10/2015 - 06/2015
2	Peroxidase (Myeloperoxidase)IBA 11/2013 - 01/2009
2	Phosphodiesterase 5 InhibitorsIBA 12/2011 - 04/2008
2	Milrinone (Primacor)FDA LinkGeneric 01/2009 - 01/2007
2	Heparin (Liquaemin)FDA LinkGeneric 07/2004 - 02/2004
2	Factor XIIa (Coagulation Factor XIIa)IBA 02/2004 - 10/2002
1	Oxyhemoglobins (Oxyhemoglobin)IBA 06/2022
1	SmokeIBA 01/2022
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2022
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 01/2022
1	HaptoglobinsIBA 01/2022
1	GlycosaminoglycansIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Factor XII (Hageman Factor)IBA 01/2022
1	KaolinIBA 01/2022
1	Purinergic Receptors (Receptors, Purine)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022

Therapy/Procedure

17	Therapeutics 01/2022 - 03/2011
8	Artificial Respiration (Mechanical Ventilation) 01/2022 - 08/2010
6	Mechanical Ventilators (Ventilator) 10/2021 - 11/2013
3	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 11/2020 - 12/2017
3	Cardiopulmonary Bypass (Heart-Lung Bypass) 10/2008 - 02/2004
2	Injections 01/2021 - 10/2010
2	Critical Care (Surgical Intensive Care) 05/2020 - 04/2018
2	Blood Transfusion (Blood Transfusions) 01/2018 - 01/2017